Betamethasone Sodium Phosphate And Betamethasone Acetate Injection, Suspension
Product Images NDC 0517-0791

5 FDA label images from American Regent, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Betamethasone Sodium Phosphate And Betamethasone Acetate (NDC 0517-0791). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Regent, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Betamethasone Novaplus 1)

Structural Formula (Betamethasone Novaplus 1)
Chemical structure diagram of Betamethasone Sodium Phosphate and Betamethasone Acetate, showing its molecular composition and arrangement of atoms.*
FDA Label Image

Structural Formula (Betamethasone Novaplus 2)

Structural Formula (Betamethasone Novaplus 2)
Chemical structure diagram of Betamethasone as the active ingredient in the injection suspension product Betamethasone Sodium Phosphate and Betamethasone Acetate by American Regent, Inc.*
FDA Label Image

Container Label Novaplus (Betamethasone Novaplus 3)

Container Label Novaplus (Betamethasone Novaplus 3)
Label for Betamethasone Sodium Phosphate and Betamethasone Acetate Injection Suspension, USP, 5 mL multiple dose vial containing 30 mg/5 mL (6 mg/mL). The label includes the NDC 0517-0791-01 and indicates the product is sterile and Rx only. The labeler is American Regent, Inc., Shirley, NY.*
FDA Label Image

Carton Labeling Novaplus (Betamethasone Novaplus 4)

Carton Labeling Novaplus (Betamethasone Novaplus 4)
Packaging label for Betamethasone Sodium Phosphate and Betamethasone Acetate Injection, Suspension, USP. The label indicates a 5 mL multiple dose vial containing 30 mg per 5 mL (6 mg per mL). It is manufactured by American Regent, Inc. The label includes directions to shake well before use, specifies intramuscular, intra-articular, intralesional, intrabursal, and intradermal routes, and cautions against intravenous use.*
FDA Label Image

Beta Novaplus Serialization Label (Betamethasone Novaplus 5)

Beta Novaplus Serialization Label (Betamethasone Novaplus 5)
Lot and expiration label for Betamethasone Sodium Phosphate and Betamethasone Acetate Injection, Suspension showing a QR code, lot number labeled as TEST, expiration date listed as 11 2020, GTIN code, and serial number 0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.